Treatment Monitoring in Multiple Sclerosis - Efficacy and Safety

被引:0
作者
Mahmoudi, Nima [1 ]
Wattjes, Mike P. [2 ,3 ,4 ]
机构
[1] Hannover Med Sch, Dept Diagnost & Intervent Neuroradiol, Hannover, Germany
[2] Charite Univ Med Berlin, Dept Neuroradiol, Charite Pl 1, D-10117 Berlin, Germany
[3] Free Univ Berlin, Berlin, Germany
[4] Humboldt Univ, Berlin, Germany
关键词
Multiple sclerosis; MR imaging; Treatment and safety monitoring; Pharmacovigilance; PML; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; DISEASE-ACTIVITY; DIAGNOSTIC-CRITERIA; MS LESIONS; LEPTOMENINGEAL INFLAMMATION; CONSENSUS RECOMMENDATIONS; GADOLINIUM ENHANCEMENT; ENHANCING LESIONS; ASYMPTOMATIC PML; INTERFERON-BETA;
D O I
10.1016/j.nic.2024.03.009
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
[No abstract available]
引用
收藏
页码:439 / 452
页数:14
相关论文
共 102 条
[1]   Leptomeningeal gadolinium enhancement across the spectrum of chronic neuroinflammatory diseases [J].
Absinta, Martina ;
Cortese, Irene C. M. ;
Vuolo, Luisa ;
Nair, Govind ;
de Alwis, Manori P. ;
Ohayon, Joan ;
Meani, Alessandro ;
Martinelli, Vittorio ;
Scotti, Roberta ;
Falini, Andrea ;
Smith, Bryan R. ;
Nath, Avindra ;
Jacobson, Steven ;
Filippi, Massimo ;
Reich, Daniel S. .
NEUROLOGY, 2017, 88 (15) :1439-1444
[2]   Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions [J].
Absinta, Martina ;
Sati, Pascal ;
Schindler, Matthew ;
Leibovitch, Emily C. ;
Ohayon, Joan ;
Wu, Tianxia ;
Meani, Alessandro ;
Filippi, Massimo ;
Jacobson, Steven ;
Cortese, Irene C. M. ;
Reich, Daniel S. .
JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (07) :2597-2609
[3]   Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis [J].
Absinta, Martina ;
Vuolo, Luisa ;
Rao, Anuradha ;
Nair, Govind ;
Sati, Pascal ;
Cortese, Irene C. M. ;
Ohayon, Joan ;
Fenton, Kaylan ;
Reyes-Mantilla, Maria I. ;
Maric, Dragan ;
Calabresi, Peter A. ;
Butman, John A. ;
Pardo, Carlos A. ;
Reich, Daniel S. .
NEUROLOGY, 2015, 85 (01) :18-28
[4]   Cryptococcal Meningoencephalitis in a Patient With Multiple Sclerosis Treated With Fingolimod [J].
Achtnichts, Lutz ;
Obreja, Otilia ;
Conen, Anna ;
Fux, Christoph A. ;
Nedeltchev, Krassen .
JAMA NEUROLOGY, 2015, 72 (10) :1203-+
[5]  
Arnold DL, 2022, CMSC M MD US NAT HAR
[6]   Effect of siponimod on magnetic resonance imaging measures of neurodegeneration and myelination in secondary progressive multiple sclerosis: Gray matter atrophy and magnetization transfer ratio analyses from the EXPAND phase 3 trial [J].
Arnold, Douglas L. ;
Piani-Meier, Daniela ;
Bar-Or, Amit ;
Benedict, Ralph H. B. ;
Cree, Bruce A. C. ;
Giovannoni, Gavin ;
Gold, Ralf ;
Vermersch, Patrick ;
Arnould, Sophie ;
Dahlke, Frank ;
Hach, Thomas ;
Ritter, Shannon ;
Karlsson, Goeril ;
Kappos, Ludwig ;
Fox, Robert J. .
MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (10) :1526-1540
[7]   Acute demyelinating lesions with restricted diffusion in multiple sclerosis [J].
Balashov, Konstantin E. ;
Lindzen, Eric .
MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (12) :1745-1753
[8]   The neuroradiology of progressive multifocal leukoencephalopathy: a clinical trial perspective [J].
Baldassari, Laura E. ;
Wattjes, Mike P. ;
Cortese, Irene C. M. ;
Gass, Achim ;
Metz, Imke ;
Yousry, Tarek ;
Reich, Daniel S. ;
Richert, Nancy .
BRAIN, 2022, 145 (02) :426-440
[9]   RELAPSING-REMITTING MULTIPLE-SCLEROSIS - SEQUENTIAL ENHANCED MR IMAGING VS CLINICAL FINDINGS IN DETERMINING DISEASE-ACTIVITY [J].
BARKHOF, F ;
SCHELTENS, P ;
FREQUIN, STFM ;
NAUTA, JJP ;
TAS, MW ;
VALK, J ;
HOMMES, OR .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1992, 159 (05) :1041-1047
[10]   PML diagnostic criteria Consensus statement from the AAN Neuroinfectious Disease Section [J].
Berger, Joseph R. ;
Aksamit, Allen J. ;
Clifford, David B. ;
Davis, Larry ;
Koralnik, Igor J. ;
Sejvar, James J. ;
Bartt, Russell ;
Major, Eugene O. ;
Nath, Avindra .
NEUROLOGY, 2013, 80 (15) :1430-1438